3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
2
Breast Neoplasms
2
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Leukemia
1
Fatigue
1
Depression
1
Colonic Neoplasms
1
Cardiotoxicity
1
Anxiety Disorders
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Exercise Test
×
Clear all
No trials found.